IP Library › Granted Patent US 12,226,558
Granted Patent B2
US 12,226,558 · App. 17/878,680 · Granted Feb 18, 2025

Dialysis system including a water treatment device

Inventor: Justin B. Rohde (Des Plaines, IL)
Assignees: Baxter International Inc.; Baxter Healthcare SA
A61M1/1656A61M1/166A61M5/44G16H40/63A61M2205/3553A61M2205/502G16H20/40G16H40/67
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,226,558
App. No.
17/878,680
Filed
Aug 1, 2022
Granted
Feb 18, 2025
Kind
B2
Art Unit
1758
USPC
210/143
Abstract

A dialysis system is disclosed. An example dialysis system includes a water treatment device configured to provide purified water and a dialysis machine including a dialysate holding tank, and a dialysate mixing pump connected to a source of concentrate. The dialysis machine is configured to prepare dialysate using the purified water by receiving an indication that a batch of dialysate is needed, transmitting a first message to the water treatment device to begin providing the purified water, and causing the dialysate mixing pump to pump a concentrate from the source of concentrate for mixing with the purified water to form the dialysate for storage in the dialysate holding tank. After the batch of the dialysate has been stored to the dialysate holding tank, the dialysis machine transmits a second message to the water treatment device to stop providing the purified water.

Claims (36)

1. A dialysis system comprising:

a water treatment device including a water treatment processor, the water treatment device fluidly connected to a water source and configured to provide purified water; and

a dialysis machine including a dialysis machine processor, a dialysate holding tank, and at least one dialysate mixing pump connected to a source of concentrate, the dialysis machine processor communicatively coupled to the water treatment processor for preparing dialysate using the purified water provided by the water treatment device, wherein the dialysis machine processor is configured to:

receive an indication that a batch of dialysate is needed,

transmit a first message to the water treatment processor to begin providing the purified water,

cause the at least one dialysate mixing pump to pump a concentrate from the source of concentrate for mixing with the purified water to form the dialysate for storage in the dialysate holding tank, and

after the batch of the dialysate has been stored in the dialysate holding tank, transmit a second message to the water treatment processor to stop providing the purified water.

2. The dialysis system of claim 1 , wherein the indication that the batch of the dialysate is needed includes determining that a volume of the dialysate within the dialysate holding tank is below a certain low level.

3. The dialysis system of claim 1 , wherein the dialysis machine processor is further configured to:

determine or receive an indication that the dialysate within the dialysate holding tank has reached a certain high level; and

transmit the second message after determining or receiving the indication that the dialysate within the dialysate holding tank has reached the certain high level.

4. The dialysis system of claim 1 , wherein the indication that the batch of the dialysate is needed includes a detected time of use for a dialysis treatment.

5. The dialysis system of claim 1 , wherein the first message includes an indication of a flow rate for the purified water.

6. The dialysis system of claim 5 , wherein the dialysis machine processor is further configured to:

determine a higher rate of production for the dialysate is needed; and

transmit another first message to the water treatment processor indicative of a higher, second flow rate for the purified water.

7. The dialysis system of claim 6 , wherein the dialysis machine processor is further configured to cause the at least one dialysate mixing pump to pump the concentrate from the source of concentrate at a faster rate for mixing with the purified water to form the dialysate for storage in the dialysate holding tank.

8. The dialysis system of claim 5 , wherein the flow rate for the purified water is determined by the dialysis machine processor as being proportional to dialysate fluid flow rate or dialysis fluid demand.

9. The dialysis system of claim 1 , wherein the dialysis machine further includes a user interface for receiving the indication that the batch of the dialysate is needed.

10. The dialysis system of claim 1 , wherein the dialysis machine includes at least one of a hemodialysis machine, a peritoneal dialysis machine, a hemofiltration machine, or a hemodiafiltration machine.

11. The dialysis system of claim 1 , wherein the water source includes an online water source and the purified water has a purity corresponding to an injectable quality or a sterile quality.

12. The dialysis system of claim 1 , wherein the concentrate includes dextrose or glucose concentrate.

13. A dialysis system comprising:

a water treatment device including a water treatment processor, the water treatment device fluidly connected to a water source and configured to provide purified water; and

a dialysis machine including a dialysis machine processor, a dialysate holding tank, and at least one dialysate mixing pump connected to a source of concentrate, the dialysis machine processor communicatively coupled to the water treatment processor for preparing dialysate using the purified water provided by the water treatment device, wherein the dialysis machine processor is configured to:

receive an indication that a batch of dialysate is needed,

transmit a message to the water treatment processor indicative of needed volume of purified water, and

cause the at least one dialysate mixing pump to pump a concentrate from the source of concentrate for mixing with the purified water to form the dialysate for storage in the dialysate holding tank,

wherein the water treatment processor is configured to stop providing the purified water to the dialysis machine when the needed volume of purified water has been reached.

14. The dialysis system of claim 13 , wherein the indication that the batch of the dialysate is needed includes determining that a volume of the dialysate within the dialysate holding tank is below a certain low level.

15. The dialysis system of claim 13 , wherein the indication that the batch of the dialysate is needed includes a detected time of use for a dialysis treatment.

16. The dialysis system of claim 13 , wherein the dialysis machine further includes a user interface for receiving the indication that the batch of the dialysate is needed.

17. The dialysis system of claim 13 , wherein the message includes an indication of a flow rate for the purified water, and

wherein the dialysis machine processor is further configured to:

determine a higher rate of production for the dialysate is needed; and

transmit another message to the water treatment processor indicative of a higher, second flow rate for the purified water.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 073413/0198 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 074046/0342 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2022
From: ROHDE, JUSTIN B.
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 060699/0702 →
Continuity (6)
Continuation 15825878 · Nov 29, 2017
Continuation 13828822 · Mar 14, 2013
Continuation In Part 13494259 · Jun 12, 2012
Continuation 13030909 · Feb 18, 2011
Continuation 12031605 · Feb 14, 2008
Related Publication 20220362446A1 · Nov 17, 2022
References Cited (93)
US 5236476A · Klick · 1993 [cited by applicant]
US 5259954A · Taylor · 1993 [cited by applicant]
US 5274434A · Morioka et al. · 1993 [cited by applicant]
US 5658456A · Kenley et al. · 1997 [cited by applicant]
US 6280634B1 · Shah · 2001 [cited by examiner]
US 6582385B2 · Burbank et al. · 2003 [cited by applicant]
US 6861033B2 · Mullins et al. · 2005 [cited by applicant]
US 7419587B2 · Valbjoern et al. · 2008 [cited by applicant]
US 7544300B2 · Brugger et al. · 2009 [cited by applicant]
US 7749393B2 · Brugger et al. · 2010 [cited by applicant]
US 7892423B2 · Rohde et al. · 2011 [cited by applicant]
US 7976711B2 · Brugger et al. · 2011 [cited by applicant]
US 8071055B2 · Newcombe · 2011 [cited by applicant]
US 8177977B2 · Gaignet · 2012 [cited by applicant]
US 8192387B2 · Brugger et al. · 2012 [cited by applicant]
US 8216452B2 · Rohde et al. · 2012 [cited by applicant]
US 8246826B2 · Wilt et al. · 2012 [cited by applicant]
US 8354029B2 · Hank · 2013 [cited by applicant]
US 8357298B2 · Demers et al. · 2013 [cited by applicant]
US 8409441B2 · Wilt et al. · 2013 [cited by applicant]
US 8425767B2 · Fava et al. · 2013 [cited by applicant]
US 20030135250A1 · Lauman et al. · 2003 [cited by applicant]
US 20030220605A1 · Bowman et al. · 2003 [cited by applicant]
US 20080045877A1 · Evin et al. · 2008 [cited by applicant]
US 20080097283A1 · Plahey · 2008 [cited by examiner]
US 20080210606A1 · Burbank · 2008 [cited by applicant]
US 20090008318A1 · Anes et al. · 2009 [cited by applicant]
US 20090008331A1 · Wilt · 2009 [cited by examiner]
US 20090045121A1 · Kabayama et al. · 2009 [cited by applicant]
US 20090182263A1 · Burbank · 2009 [cited by examiner]
US 20090218285A1 · Hank · 2009 [cited by examiner]
US 20100018923A1 · Rohde et al. · 2010 [cited by applicant]
US 20100051546A1 · Vuong et al. · 2010 [cited by applicant]
US 20100078092A1 · Weilhoefer et al. · 2010 [cited by applicant]
US 20100137693A1 · Porras et al. · 2010 [cited by applicant]
US 20100326916A1 · Wrazel et al. · 2010 [cited by applicant]
US 20100332149A1 · Scholpp · 2010 [cited by applicant]
US 20110100913A1 · Minami et al. · 2011 [cited by applicant]
US 20110180480A1 · Kloeffel et al. · 2011 [cited by applicant]
US 20110186521A1 · Burbank et al. · 2011 [cited by applicant]
US 20110192796A1 · Smejtek et al. · 2011 [cited by applicant]
US 20110315611A1 · Fulkerson et al. · 2011 [cited by applicant]
US 20120138533A1 · Curtis et al. · 2012 [cited by applicant]
US 20130008854A1 · Wallace et al. · 2013 [cited by applicant]
US 20130020237A1 · Wilt et al. · 2013 [cited by applicant]
US 20140238912A1 · Vincent · 2014 [cited by applicant]
US 20160058933A1 · Ballantyne · 2016 [cited by examiner]
DE 19605260 · 1996 [cited by applicant]
EP 1614437 · 2006 [cited by applicant]
EP 2180908 · 2010 [cited by applicant]
EP 2181965 · 2010 [cited by applicant]
JP 2003513714 · 2003 [cited by applicant]
JP 2003199719 · 2003 [cited by applicant]
JP 2005503179 · 2005 [cited by applicant]
JP 200823324A · 2008 [cited by applicant]
JP 2010279423A · 2010 [cited by applicant]
JP 2012530577 · 2012 [cited by applicant]
WO 9625214 · 1996 [cited by applicant]
WO 9640318 · 1996 [cited by applicant]
WO 2012120078 · 2003 [cited by applicant]
WO 2007118235 · 2007 [cited by applicant]
WO 2007148442A1 · 2007 [cited by applicant]
WO 2008138311 · 2008 [cited by applicant]
WO 2011069110 · 2011 [cited by applicant]
WO 2012129501 · 2012 [cited by applicant]
WO WO2012129501A2 · 2012 [cited by applicant]
WO 2013173349A2 · 2013 [cited by applicant]
Final Office Action for related Japanese Application No. 2021-008641; action dated Aug. 2, 2022; (3 pages). [cited by applicant]
European Communication dated Mar. 2, 2015 for Application No. 09 710 209.9-1662, 6 pages. [cited by applicant]
Office Action for Mexican Patent Application No. Mx/a/2010/008961 received Jul. 1, 2013. [cited by applicant]
Manns et al., The Acu-men TM: A new device for continuous renal replacement therapy in acute renal failure, Kidney International, 1998, pp. 268-275, vol. 54. [cited by applicant]
Search and Examination Report dated Jul. 29, 2014 for related GB Appln. No. 1322331.8. [cited by applicant]
European Search Report—EP Application No. 16 17 6496 dated Mar. 21, 2017—10 pages. [cited by applicant]
U.S. Appl. No. 60/903,582, filed Feb. 27, 2007. [cited by applicant]
U.S. Appl. No. 60/904,024, filed Feb. 27, 2007. [cited by applicant]
U.S. Appl. No. 61/092,239, filed Aug. 27, 2008. [cited by applicant]
U.S. Appl. No. 61/489,544, filed May 24, 2011. [cited by applicant]
U.S. Appl. No. 61/489,394, filed Jun. 17, 2011. [cited by applicant]
U.S. Appl. No. 62/003,374, filed May 27, 2014. [cited by applicant]
U.S. Appl. No. 62/004,567, filed May 29, 2014. [cited by applicant]
Search Report issued in French application No. 1452117, dated Mar. 31, 2016, 2 pages. [cited by applicant]
Written Opinion issued in French application No. 1452117, dated Mar. 31, 2016, 5 pages. [cited by applicant]
Notice of Reasons for Rejection mailed on Dec. 5, 2017 in corresponding JP Application No. 2013-257132. [cited by applicant]
German Office Action for related German Application No. 102014204546.0; action dated Apr. 24, 2018; (12 pages). [cited by applicant]
Japanese Office Action for related Japanese Application No. 2013-257132; action dated Aug. 14, 2018; (4 pages). [cited by applicant]
Mexican Office Action and English translation for related Mexican Application No. MX/a/2014/001566; action forwarded Nov. 6, 2018; (6 pages). [cited by applicant]
Canadian Office Action for application No. 2836575, dated Nov. 13, 2019—4 pages. [cited by applicant]
Japanese Office Action for related Japanese Application No. 2018-233707; action dated Sep. 23, 2020; (4 pages). [cited by applicant]
Mexican Office Action and English translation for related Mexican Application No. MX/a/2019/001526; action forwarded Dec. 10, 2021; (7 pages). [cited by applicant]
Japanese Office Action for related Japanese Application No. 2021-008641; action dated Jan. 11, 2022; (15 pages). [cited by applicant]
Office Action for related Japanese Application No. 2019-571624; report dated Mar. 22, 2022; (14 pages). [cited by applicant]
Office Action received in related application No. 20 180 920.9-1122, dated Jun. 5, 2023. [cited by applicant]
JP 2022-193339 Notice of Reasons For Rejection with English language translation, dated Feb. 1, 2024 with English language translation. [cited by applicant]